Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

TURN
180 Degree Capital Corp
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Dec 2016 30 Sep 2016 30 Jun 2016 31 Mar 2016
Current assets
Cash $15.433919 $13.38482 $11.841767 $14.311324
Short term investments
Net receivables $0.079243 $0.593058 $0.170541
Inventory
Total current assets
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments $58.334309 $67.996587 $75.020758 $73.521729
Total assets $74.622068 $82.422674 $88.428366 $89.53337
Current liabilities
Accounts payable $0.877132 $0.632715 $0.671828 $0.550999
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $5 $5 $5
Total liabilities $2.366458 $7.099725 $7.144084 $7.028125
Stockholders' equity
Retained earnings -$139.653193 -$136.543529 -$130.521492 -$129.336447
Other stockholder equity $0.300237 $0.352482 $0.404728 $0.456974
Total stockholder equity $72.25561 $75.322949 $81.284282 $82.505245
(in millions USD) 2016 2015 2014
Current assets
Cash $15.433919 $17.92263 $20.748314
Short term investments
Net receivables $0.013032 $0.160877
Inventory
Total current assets
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments $58.334309 $77.152904 $89.76484
Total assets $74.622068 $96.461286 $112.094861
Current liabilities
Accounts payable $0.877132 $1.268355 $0.841915
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $5
Total liabilities $2.366458 $7.749615 $2.440434
Stockholders' equity
Retained earnings -$139.653193 -$123.286833 -$103.041003
Other stockholder equity $0.300237 $0.50922 $0.718203
Total stockholder equity $72.25561 $88.711671 $109.654427

Income statement

XSLX
XSLX
(in millions USD) 31 Dec 2016 30 Sep 2016 30 Jun 2016 31 Mar 2016
Revenue
Total revenue $0.463954 $0.566152 $0.460042 $0.302042
Cost of revenue
Gross profit $0.463954 $0.566152 $0.460042 $0.302042
Operating activities
Research & development
Selling, general & administrative $1.502807 $1.06029 $1.164242 $1.127692
Total operating expenses $1.652073 $1.213086 $1.300323 $1.255942
Operating income -$1.188119 -$0.646934 -$0.840281 -$0.9539
Income from continuing operations
EBIT -$2.851446 -$5.812156 -$0.978359 -$5.835758
Income tax expense -$0.002774 $0.00005 -$0.001339 $0.00583
Interest expense $0.260992 $0.209831 $0.208025 $0.208026
Net income
Net income -$3.109664 -$6.022037 -$1.185045 -$6.049614
Income (for common shares) -$3.109664 -$6.022037 -$1.185045 -$6.049614
(in millions USD) 2016 2015 2014
Revenue
Total revenue $1.79219 $0.916995 $0.5178
Cost of revenue
Gross profit $1.79219 $0.916995 $0.5178
Operating activities
Research & development
Selling, general & administrative $4.855031 $6.670468 $7.367759
Total operating expenses $5.421424 $7.308097 $8.041869
Operating income -$3.629234 -$6.391102 -$7.524069
Income from continuing operations
EBIT -$15.477719 -$19.472274 -$13.174866
Income tax expense $0.001767 $0.002148 $0.017896
Interest expense $0.886874 $0.771408 $0.377658
Net income
Net income -$16.36636 -$20.24583 -$13.57042
Income (for common shares) -$16.36636 -$20.24583 -$13.57042

Cash flows

XSLX
XSLX
(in millions USD) 31 Dec 2016 30 Sep 2016 30 Jun 2016 31 Mar 2016
Net income -$3.109664 -$6.022037 -$1.185045 -$6.049614
Operating activities
Depreciation $0.00017 -$0.122497 -$0.121992 -$0.108842
Business acquisitions & disposals
Stock-based compensation $0.111946 $0.11295 $0.038643 -$0.104566
Total cash flows from operations $7.066475 $1.544491 -$2.447242 -$3.611306
Investing activities
Capital expenditures -$0.001438
Investments
Total cash flows from investing -$0.001438
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$5
Total cash flows from financing -$5.017376 -$0.022315
Effect of exchange rate
Change in cash and equivalents $2.049099 $1.543053 -$2.469557 -$3.611306
(in millions USD) 2016 2015 2014
Net income -$16.36636 -$20.24583 -$13.57042
Operating activities
Depreciation -$0.353161 -$0.469224 -$0.109857
Business acquisitions & disposals
Stock-based compensation $0.158973 $0.798965 $0.857006
Total cash flows from operations $2.552418 -$6.52996 $12.361457
Investing activities
Capital expenditures -$0.001438 -$0.008816 -$0.02694
Investments
Total cash flows from investing -$0.001438 -$0.008816 -$0.02694
Financing activities
Dividends paid
Sale and purchase of stock -$1.199994
Net borrowings -$5 $5
Total cash flows from financing -$5.039691 $3.713092 -$0.124751
Effect of exchange rate
Change in cash and equivalents -$2.488711 -$2.825684 $12.209766

FCCY
1st Constitution Bancorp
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $273.946 $215.677 $165.901 $21.995
Short term investments
Net receivables
Inventory
Total current assets
Long term investments
Property, plant & equipment $29.117 $29.75 $30.328 $30.893
Goodwill & intangible assets $35.765 $35.844 $35.922 $36.003
Total noncurrent assets
Total investments $1,517.201 $1,453.413 $1,519.891 $1,665.596
Total assets $1,910.54 $1,789.245 $1,806.231 $1,806.909
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $34.773 $35.169 $35.55 $45.769
Total liabilities $1,710.617 $1,593.588 $1,614.968 $1,619.252
Stockholders' equity
Retained earnings $87.735 $83.333 $79.208 $75.201
Other stockholder equity $0.821 $1.288 $1.334 $1.932
Total stockholder equity $199.923 $195.657 $191.263 $187.657
(in millions USD) 2020 2019 2018
Current assets
Cash $21.995 $14.842 $16.844
Short term investments
Net receivables
Inventory
Total current assets
Long term investments
Property, plant & equipment $30.893 $33.219 $11.653
Goodwill & intangible assets $36.003 $36.779 $12.258
Total noncurrent assets
Total investments $1,665.596 $1,445.086 $1,089.576
Total assets $1,806.909 $1,586.262 $1,177.833
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $45.769 $129.224 $90.332
Total liabilities $1,619.252 $1,415.684 $1,050.748
Stockholders' equity
Retained earnings $75.201 $60.791 $49.75
Other stockholder equity $1.932 $0.191 -$1.833
Total stockholder equity $187.657 $170.578 $127.085

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $18.111 $17.575 $17.956 $19.36
Cost of revenue
Gross profit $18.111 $17.575 $17.956 $19.36
Operating activities
Research & development
Selling, general & administrative $8.334 $8.125 $8.754 $9.053
Total operating expenses $10.841 $10.531 $11.101 $11.163
Operating income $7.27 $7.044 $6.855 $8.197
Income from continuing operations
EBIT $7.27 $7.044 $6.855 $8.197
Income tax expense $1.84 $1.892 $1.926 $2.132
Interest expense
Net income
Net income $5.43 $5.152 $4.929 $6.065
Income (for common shares) $5.43 $5.152 $4.929 $6.065
(in millions USD) 2020 2019 2018
Revenue
Total revenue $66.448 $54.223 $50.45
Cost of revenue
Gross profit $66.448 $54.223 $50.45
Operating activities
Research & development
Selling, general & administrative $33.328 $26.911 $24.808
Total operating expenses $41.755 $35.549 $34.085
Operating income $24.693 $18.674 $16.365
Income from continuing operations
EBIT $24.693 $18.674 $16.365
Income tax expense $6.607 $5.04 $4.317
Interest expense
Net income
Net income $18.086 $13.634 $12.048
Income (for common shares) $18.086 $13.634 $12.048

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income $5.43 $5.152 $4.929 $6.065
Operating activities
Depreciation $0.467 $0.483 $0.476 $0.492
Business acquisitions & disposals
Stock-based compensation $0.258 $0.302 $0.271 $0.276
Total cash flows from operations $30.503 $10.108 $26.789 $19.073
Investing activities
Capital expenditures -$0.102 -$0.166 -$0.184 -$0.173
Investments -$64.316 $56.006 $129.742 $28.163
Total cash flows from investing -$63.779 $55.84 $129.558 $27.991
Financing activities
Dividends paid -$1.028 -$1.027 -$0.922 -$0.922
Sale and purchase of stock $0.073 $0.013 -$0.074 $0.034
Net borrowings -$9.825 -$96.042
Total cash flows from financing $91.545 -$16.172 -$12.441 -$45.124
Effect of exchange rate
Change in cash and equivalents $58.269 $49.776 $143.906 $1.94
(in millions USD) 2020 2019 2018
Net income $18.086 $13.634 $12.048
Operating activities
Depreciation $2.053 $1.444 $1.389
Business acquisitions & disposals $7.44 -$0.996
Stock-based compensation $1.132 $1.104 $1.019
Total cash flows from operations $6.659 $13.262 $17.328
Investing activities
Capital expenditures -$0.421 -$0.161 -$0.648
Investments -$198.637 -$117.128 -$9.348
Total cash flows from investing -$198.878 -$109.949 -$9.924
Financing activities
Dividends paid -$3.676 -$2.593 -$2.12
Sale and purchase of stock -$0.204 $0.149 $0.088
Net borrowings -$82.225 $20.275 $51.275
Total cash flows from financing $199.372 $94.685 -$9.314
Effect of exchange rate
Change in cash and equivalents $7.153 -$2.002 -$1.91

ABEO
Abeona Therapeutics Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $34.764 $17.896 $14.811 $5.05
Short term investments $88.282 $44.786 $37.753 $49.042
Net receivables $1.64 $2.232 $2.444 $2.209
Inventory
Total current assets $125.904 $66.725 $55.737 $57.264
Long term investments
Property, plant & equipment $7.999 $7.989 $7.988 $8.684
Goodwill & intangible assets
Total noncurrent assets $8.099 $8.103 $8.265 $8.823
Total investments $88.282 $44.786 $37.753 $49.042
Total assets $134.003 $74.828 $64.002 $66.087
Current liabilities
Accounts payable $3.099 $3.362 $1.858 $7.064
Deferred revenue
Short long term debt $4.014 $1.044 $0.998 $1.649
Total current liabilities $16.843 $11.889 $13.422 $8.412
Long term debt $19.151 $22.125 $4.402 $4.043
Total noncurrent liabilities $43.919 $71.82 $35.754 $35.637
Total debt $23.165 $23.169 $5.4 $5.692
Total liabilities $60.762 $83.709 $49.176 $44.049
Stockholders' equity
Retained earnings -$773.696 -$781.102 -$749.524 -$732.933
Other stockholder equity -$0.134 -$0.184 -$0.066 -$0.099
Total stockholder equity $73.241 -$8.881 $14.826 $22.038
(in millions USD) 2023 2022 2021
Current assets
Cash $14.811 $14.555 $32.938
Short term investments $37.753 $37.932 $12.086
Net receivables $2.444 $0.188 $3
Inventory
Total current assets $55.737 $53.099 $55.401
Long term investments
Property, plant & equipment $7.988 $11.072 $21.742
Goodwill & intangible assets $1.384
Total noncurrent assets $8.265 $11.115 $24.185
Total investments $37.753 $37.932 $12.086
Total assets $64.002 $64.214 $79.586
Current liabilities
Accounts payable $1.858 $5.974 $8.153
Deferred revenue $0.296
Short long term debt $0.998 $1.773 $1.818
Total current liabilities $13.422 $7.779 $16.623
Long term debt $4.402 $5.854 $7.56
Total noncurrent liabilities $35.754 $29.674 $11.588
Total debt $5.4 $7.627 $9.378
Total liabilities $49.176 $37.453 $28.211
Stockholders' equity
Retained earnings -$749.524 -$695.336 -$655.64
Other stockholder equity -$0.066 -$0.129 -$0.027
Total stockholder equity $14.826 $26.761 $51.375

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $9.218 $7.207 $7.379 $7.148
Selling, general & administrative $8.646 $7.123 $5.83 $4.156
Total operating expenses $17.864 $14.33 $13.209 $11.304
Operating income -$17.864 -$14.33 -$13.209 -$11.304
Income from continuing operations
EBIT $8.478 -$30.626 -$16.482 -$11.731
Income tax expense
Interest expense $1.072 $0.952 $0.109 $0.105
Net income
Net income $7.406 -$31.578 -$16.591 -$11.836
Income (for common shares) $7.406 -$31.578 -$16.591 -$11.836
(in millions USD) 2023 2022 2021
Revenue
Total revenue $3.5 $1.414 $3
Cost of revenue
Gross profit $3.5 $1.414 $3
Operating activities
Research & development $31.091 $28.965 $34.325
Selling, general & administrative $19.004 $17.256 $22.795
Total operating expenses $49.03 $51.879 $92.836
Operating income -$45.53 -$50.465 -$89.836
Income from continuing operations
EBIT -$53.77 -$38.96 -$81.266
Income tax expense
Interest expense $0.418 $0.736 $3.67
Net income
Net income -$54.188 -$39.696 -$84.936
Income (for common shares) -$54.188 -$43.478 -$84.936

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $7.406 -$31.578 -$16.591 -$11.836
Operating activities
Depreciation $0.685 $0.724 $0.721 $0.751
Business acquisitions & disposals
Stock-based compensation $1.323 $1.546 $1.514 $1.557
Total cash flows from operations -$12.684 -$14.538 -$9.235 -$5.746
Investing activities
Capital expenditures -$0.693 -$0.725 -$0.02 -$0.036
Investments -$43.439 -$7.092 $11.549 -$18.707
Total cash flows from investing -$44.132 -$7.817 $11.529 -$18.743
Financing activities
Dividends paid
Sale and purchase of stock $73.684 $6.403 $7.617 $22.976
Net borrowings $19.037 -$0.15
Total cash flows from financing $73.684 $25.44 $7.467 $22.976
Effect of exchange rate
Change in cash and equivalents $16.868 $3.085 $9.761 -$1.513
(in millions USD) 2023 2022 2021
Net income -$54.188 -$39.696 -$84.936
Operating activities
Depreciation $3.198 $4.577 $4.464
Business acquisitions & disposals
Stock-based compensation $4.768 $3.051 $8.916
Total cash flows from operations -$37.009 -$43.483 -$65.665
Investing activities
Capital expenditures -$0.127 $1.604 -$4.151
Investments $0.335 -$25.568 $70.213
Total cash flows from investing $0.208 -$23.964 $66.062
Financing activities
Dividends paid
Sale and purchase of stock $37.207 $46.955 $26.315
Net borrowings -$0.15
Total cash flows from financing $37.057 $43.173 $24.861
Effect of exchange rate
Change in cash and equivalents $0.256 -$24.274 $25.258

ACTG
Acacia Research Corp
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $386.988 $438.762 $340.091 $344.733
Short term investments $54.924 $59.668 $99.818 $101.261
Net receivables $18.772 $15.372 $80.555 $5.896
Inventory $12.289 $9.88 $10.921 $12.375
Total current assets $493.934 $553.147 $554.512 $484.447
Long term investments
Property, plant & equipment $196.541 $28.759 $29.345 $4.135
Goodwill & intangible assets $45.007 $38.68 $42.546 $35.098
Total noncurrent assets $259.659 $78.578 $79.033 $44.7
Total investments $54.924 $59.668 $99.818 $101.261
Total assets $753.593 $631.725 $633.545 $529.147
Current liabilities
Accounts payable $3.191 $4.702 $3.261 $8.53
Deferred revenue $0.911 $1.425 $1.435 $1.646
Short long term debt
Total current liabilities $44.204 $25.846 $27.636 $21.433
Long term debt $83.447 $14.502 $12.261 $1.535
Total noncurrent liabilities $112.644 $16.275 $16.3 $4.116
Total debt $83.447 $14.502 $12.261 $1.535
Total liabilities $156.848 $42.121 $43.936 $25.549
Stockholders' equity
Retained earnings -$248.361 -$239.915 -$239.729 -$314.485
Other stockholder equity
Total stockholder equity $560.696 $568.264 $568.266 $492.556
(in millions USD) 2023 2022 2021
Current assets
Cash $340.091 $287.786 $308.943
Short term investments $99.818 $98.358 $398.528
Net receivables $80.555 $8.231 $9.517
Inventory $10.921 $14.222 $8.93
Total current assets $554.512 $427.985 $730.682
Long term investments $0.418
Property, plant & equipment $29.345 $5.542 $6.21
Goodwill & intangible assets $42.546 $44.199 $56.263
Total noncurrent assets $79.033 $54.943 $68.174
Total investments $99.818 $98.358 $398.946
Total assets $633.545 $482.928 $798.856
Current liabilities
Accounts payable $3.261 $6.036 $5.44
Deferred revenue $1.435 $1.797 $1.695
Short long term debt $60.45 $181.248
Total current liabilities $27.636 $87.209 $200.19
Long term debt $12.261 $1.873 $2.027
Total noncurrent liabilities $16.3 $106.473 $153.438
Total debt $12.261 $62.323 $183.275
Total liabilities $43.936 $193.682 $353.628
Stockholders' equity
Retained earnings -$239.729 -$306.789 -$181.724
Other stockholder equity
Total stockholder equity $568.266 $258.28 $419.433

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $25.838 $24.32 $92.311 $10.084
Cost of revenue $19.08 $12.365 $24.081 $9.847
Gross profit $6.758 $11.955 $68.23 $0.237
Operating activities
Research & development $0.178 $0.134 $0.142 $0.172
Selling, general & administrative $11.338 $13.908 $9.879 $15.485
Total operating expenses $11.516 $14.042 $10.021 $15.657
Operating income -$4.758 -$2.087 $58.209 -$15.42
Income from continuing operations
EBIT -$15.507 -$1.295 $72.611 $1.569
Income tax expense -$7.061 -$1.109 -$2.145 -$0.197
Interest expense $0.13
Net income
Net income -$8.446 -$0.186 $74.756 $1.636
Income (for common shares) -$8.446 -$0.186 $70.843 -$1.74
(in millions USD) 2023 2022 2021
Revenue
Total revenue $125.102 $59.223 $88.047
Cost of revenue $52.829 $37.388 $36.098
Gross profit $72.273 $21.835 $51.949
Operating activities
Research & development $0.735 $0.626 $0.2
Selling, general & administrative $50.602 $61.301 $37.204
Total operating expenses $51.337 $61.927 $37.404
Operating income $20.936 -$40.092 $14.545
Income from continuing operations
EBIT $67.486 -$134.844 $181.406
Income tax expense -$1.504 -$16.211 $24.287
Interest expense $1.93 $6.432 $7.922
Net income
Net income $67.06 -$125.065 $149.197
Income (for common shares) $55.14 -$133.035 $118.804

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$8.446 -$0.186 $74.756 $1.636
Operating activities
Depreciation $7.405 $4.568 $4.576 $3.363
Business acquisitions & disposals -$8.881 $2.249
Stock-based compensation $0.891 $0.858 $0.973 $0.973
Total cash flows from operations $16.116 $54.839 -$4.544 $1.16
Investing activities
Capital expenditures -$142.873 -$0.27 -$0.037 -$0.015
Investments $42.31 $12.514 -$2.835
Total cash flows from investing -$151.873 $42.04 $7.561 -$0.601
Financing activities
Dividends paid
Sale and purchase of stock $0.223 $0.029
Net borrowings $68.975 $2.5 -$7.7 -$60
Total cash flows from financing $84.054 $1.826 -$7.719 -$10.971
Effect of exchange rate -$0.071 -$0.034 $0.06 -$0.043
Change in cash and equivalents -$51.774 $98.671 -$4.642 -$10.455
(in millions USD) 2023 2022 2021
Net income $67.06 -$125.065 $149.197
Operating activities
Depreciation $14.728 $13.514 $10.688
Business acquisitions & disposals -$6.632 $28.404 -$30.888
Stock-based compensation $3.297 $3.82 $2.053
Total cash flows from operations -$22.506 -$37.336 $13.326
Investing activities
Capital expenditures -$0.189 -$0.732 -$0.091
Investments $19.034 $161.792 $87.73
Total cash flows from investing $16.178 $184.464 $35.751
Financing activities
Dividends paid
Sale and purchase of stock $79.346 -$50.988 -$3.81
Net borrowings -$67.7 -$120 $65
Total cash flows from financing $58.632 -$166.137 $59.738
Effect of exchange rate $0.001 -$2.566
Change in cash and equivalents $52.305 -$21.575 $108.815

ACHC
Acadia Healthcare Company Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $77.167 $77.303 $100.073 $99.591
Short term investments
Net receivables $389.374 $386.191 $361.451 $362.666
Inventory
Total current assets $645.214 $610.806 $596 $703.475
Long term investments
Property, plant & equipment $2,621.129 $2,497.405 $2,384.39 $2,267.689
Goodwill & intangible assets $2,334.743 $2,334.378 $2,299.24 $2,299.773
Total noncurrent assets $5,032.838 $4,906.441 $4,762.841 $4,642.743
Total investments
Total assets $5,678.052 $5,517.247 $5,358.841 $5,346.218
Current liabilities
Accounts payable $159.52 $156.13 $156.132 $149.874
Deferred revenue
Short long term debt $93.584 $88.267 $55.487 $52.805
Total current liabilities $546.522 $482.313 $885.781 $864.89
Long term debt $1,879.262 $1,897.648 $1,443.356 $1,454.827
Total noncurrent liabilities $2,066.934 $2,059.579 $1,585.4 $1,671.184
Total debt $1,972.846 $1,985.915 $1,498.843 $1,507.632
Total liabilities $2,613.456 $2,541.892 $2,471.181 $2,536.074
Stockholders' equity
Retained earnings $286.586 $208.104 $131.721 $73.992
Other stockholder equity
Total stockholder equity $2,952.718 $2,866.022 $2,781.974 $2,712.562
(in millions USD) 2023 2022 2021
Current assets
Cash $100.073 $97.649 $133.813
Short term investments
Net receivables $361.451 $322.439 $281.332
Inventory
Total current assets $596 $506.125 $495.031
Long term investments
Property, plant & equipment $2,384.39 $2,087.283 $1,904.92
Goodwill & intangible assets $2,299.24 $2,298.846 $2,270.082
Total noncurrent assets $4,762.841 $4,481.776 $4,273.047
Total investments
Total assets $5,358.841 $4,987.901 $4,768.078
Current liabilities
Accounts payable $156.132 $104.723 $98.575
Deferred revenue
Short long term debt $55.487 $47.713 $41.942
Total current liabilities $885.781 $388.326 $404.861
Long term debt $1,443.356 $1,480.97 $1,595.467
Total noncurrent liabilities $1,585.4 $1,698.591 $1,780.34
Total debt $1,498.843 $1,528.683 $1,637.409
Total liabilities $2,471.181 $2,086.917 $2,185.201
Stockholders' equity
Retained earnings $131.721 $153.388 -$119.751
Other stockholder equity
Total stockholder equity $2,781.974 $2,812.727 $2,517.489

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $796.04 $768.051 $742.8 $750.334
Cost of revenue $507.574 $501.726 $484.267 $478.568
Gross profit $288.466 $266.325 $258.533 $271.766
Operating activities
Research & development
Selling, general & administrative $109.69 $101.073 $98.108 $104.048
Total operating expenses $152.847 $140.267 $167.841 $538.422
Operating income $135.619 $126.058 $90.692 -$266.656
Income from continuing operations
EBIT $133.284 $123.671 $98.411 -$268.841
Income tax expense $25.643 $20.074 $20.208 -$71.873
Interest expense $29.159 $27.214 $20.474 $20.742
Net income
Net income $78.482 $76.383 $57.729 -$217.71
Income (for common shares) $78.482 $76.383 $57.729 -$217.71
(in millions USD) 2023 2022 2021
Revenue
Total revenue $2,928.738 $2,610.399 $2,314.394
Cost of revenue $1,900.887 $1,697.109 $1,509.764
Gross profit $1,027.851 $913.29 $804.63
Operating activities
Research & development
Selling, general & administrative $388.906 $349.277 $301.339
Total operating expenses $980.833 $469.387 $427.227
Operating income $47.018 $443.903 $377.403
Income from continuing operations
EBIT $50.759 $437.009 $335.185
Income tax expense -$9.699 $94.11 $67.557
Interest expense $82.125 $69.76 $76.993
Net income
Net income -$21.667 $273.139 $190.635
Income (for common shares) -$21.667 $273.139 $190.635

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $78.482 $76.383 $57.729 -$217.71
Operating activities
Depreciation $36.066 $36.347 $35.38 $33.388
Business acquisitions & disposals -$0.369 -$50.353 -$0.349
Stock-based compensation $8.869 $8.678 $9.149 $8.163
Total cash flows from operations $171.148 -$321.285 $116.304 $137.858
Investing activities
Capital expenditures -$153.089 -$133.354 -$109.934 -$128.039
Investments
Total cash flows from investing -$155.484 -$184.614 -$110.168 -$129.373
Financing activities
Dividends paid
Sale and purchase of stock -$0.655 -$1.013 $0.858 $0.711
Net borrowings -$15.363 $483.24 -$5.312 -$20.313
Total cash flows from financing -$15.8 $483.129 -$5.654 -$21.067
Effect of exchange rate
Change in cash and equivalents -$0.136 -$22.77 $0.482 -$12.582
(in millions USD) 2023 2022 2021
Net income -$21.667 $273.139 $190.635
Operating activities
Depreciation $132.349 $117.769 $106.717
Business acquisitions & disposals -$0.349 -$9.507 $1,372.005
Stock-based compensation $32.289 $29.635 $37.53
Total cash flows from operations $462.34 $380.569 $374.477
Investing activities
Capital expenditures -$394.711 -$289.075 -$272.719
Investments -$84.795
Total cash flows from investing -$397.219 -$305.83 $1,017.633
Financing activities
Dividends paid
Sale and purchase of stock -$44.335 -$6.179
Net borrowings -$16.25 -$113.594 -$1,648.868
Total cash flows from financing -$62.697 -$110.903 -$1,641.061
Effect of exchange rate $4.067
Change in cash and equivalents $2.424 -$36.164 -$244.884